Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cabaletta Bio Q4 EPS $(0.46) Misses $(0.39) Estimate; Cabaletta Had Cash, Cash Equivalents And Short-term Investments Of $241.2M Expected To Fund Its Operating Plan Into The First Half Of 2026

Author: Benzinga Newsdesk | March 21, 2024 07:22am
Cabaletta Bio (NASDAQ:CABA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.39) by 17.95 percent. This is a 188.46 percent decrease over earnings of $0.52 per share from the same period last year.

Posted In: CABA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist